485 related articles for article (PubMed ID: 8103763)
21. [Strong inhibition of gastric acid secretion: when is it justifiable?].
Dobrilla G; Amplaz S; Benvenuti S; Bertozzo A
G Clin Med; 1990; 71(8-9):521-6. PubMed ID: 1980653
[No Abstract] [Full Text] [Related]
22. Comparative evaluation of the hemodynamic effects of oral cimetidine, ranitidine, and famotidine as determined by echocardiography.
Welage LS; Dunn-Kucharski VA; Berardi RR; Shea MJ; Dechert RE; Bleske BE
Pharmacotherapy; 1995; 15(2):158-63. PubMed ID: 7624262
[TBL] [Abstract][Full Text] [Related]
23. Effect of pre-operative short course famotidine on tumor infiltrating lymphocytes in colorectal cancer: a double blind, placebo controlled, prospective randomized study.
Kapoor S; Pal S; Sahni P; Dattagupta S; Kanti Chattopadhyay T
J Surg Res; 2005 Dec; 129(2):172-5. PubMed ID: 15882879
[TBL] [Abstract][Full Text] [Related]
24. [Bronchial asthma and gastroesophageal reflux disease: are they interrelated by chance?].
Paleev NR; Isakov VA; Ivanova OV
Klin Med (Mosk); 2005; 83(1):9-14. PubMed ID: 15759483
[No Abstract] [Full Text] [Related]
25. Comparative study of the speed of acid-suppressing effects of oral administration of cimetidine and famotidine.
Adachi K; Komazawa Y; Mihara T; Azumi T; Fujisawa T; Katsube T; Furuta K; Kinoshita Y
J Gastroenterol Hepatol; 2005 Jul; 20(7):1012-5. PubMed ID: 15955208
[TBL] [Abstract][Full Text] [Related]
26. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
Festen HP; Schenk E; Tan G; Snel P; Nelis F
Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
[TBL] [Abstract][Full Text] [Related]
27. [Comparison between ranitidine, famotidine, and omeprazole in the treatment of bleeding duodenal ulcer].
Maculotti L; Pradella P
Minerva Chir; 1995 Mar; 50(3):279-81. PubMed ID: 7659265
[TBL] [Abstract][Full Text] [Related]
28. The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected].
Mason I; Millar LJ; Sheikh RR; Evans WM; Todd PL; Turbitt ML; Taylor MD
Aliment Pharmacol Ther; 1998 Mar; 12(3):263-71. PubMed ID: 9570261
[TBL] [Abstract][Full Text] [Related]
29. No significant difference in neutrophil activation found among three H2RAs.
Fukuda M; Shirasaka D; Aoyama N; Miki I; Kachi M; Morita Y; Tamura T; Kasuga M
Dig Liver Dis; 2007 Feb; 39(2):130-5. PubMed ID: 17161670
[TBL] [Abstract][Full Text] [Related]
30. Comparative effects of H2-receptor antagonists on drug interaction in rats.
Lin JH; Cocchetto DM; Yeh KC; Duggan DE
Drug Metab Dispos; 1986; 14(6):649-53. PubMed ID: 2877821
[TBL] [Abstract][Full Text] [Related]
31. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
[TBL] [Abstract][Full Text] [Related]
32. Prophylaxis against acid aspiration in regional anesthesia for elective cesarean section: a comparison between oral single-dose ranitidine, famotidine and omeprazole assessed with fiberoptic gastric aspiration.
Lin CJ; Huang CL; Hsu HW; Chen TL
Acta Anaesthesiol Sin; 1996 Dec; 34(4):179-84. PubMed ID: 9084544
[TBL] [Abstract][Full Text] [Related]
33. Use of i.v. cimetidine, ranitidine, and famotidine in 40 hospitals.
Segal R; Russell WL; Oh T; Ben-Joseph R
Am J Hosp Pharm; 1993 Oct; 50(10):2077-81. PubMed ID: 8238052
[TBL] [Abstract][Full Text] [Related]
34. Famotidine in the therapy of gastric hypersecretory states.
Vinayek R; Howard JM; Maton PN; Wank SA; Slaff JI; Gardner JD; Jensen RT
Am J Med; 1986 Oct; 81(4B):49-59. PubMed ID: 2877575
[TBL] [Abstract][Full Text] [Related]
35. [Effects of lansoprazole on indomethacin-induced gastric bleeding and mucosal lesions in rats].
Murakami I; Asano S; Yukishige K; Nagaya H; Satoh H; Inatomi N
Nihon Yakurigaku Zasshi; 1996 Dec; 108(6):323-32. PubMed ID: 9017686
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Maton PN; Gardner JD; Jensen RT
Gastroenterol Clin North Am; 1989 Dec; 18(4):847-63. PubMed ID: 2575602
[TBL] [Abstract][Full Text] [Related]
37. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
[TBL] [Abstract][Full Text] [Related]
38. Neurotoxic convulsions induced by histamine H2 receptor antagonists in mice.
Shimokawa M; Yamamoto K; Kawakami J; Sawada Y; Iga T
Toxicol Appl Pharmacol; 1996 Feb; 136(2):317-23. PubMed ID: 8619239
[TBL] [Abstract][Full Text] [Related]
39. Omeprazole versus histamine H2 receptor antagonists in the treatment of acute upper non-variceal bleeding.
Mohamed SA; al Karawi MA
Hepatogastroenterology; 1996; 43(10):863-5. PubMed ID: 8884305
[TBL] [Abstract][Full Text] [Related]
40. Endoscopic appearances of hemorrhagic peptic ulcers and efficacy of H2-receptor antagonists.
Fusamoto H; Kawano S; Tsuji S; Oshita M; Nagano K; Ohmae A; Sawaoka H; Nagai Y; Kasahara A; Sugimoto T; Kamada T
Hepatogastroenterology; 1996; 43(7):169-73. PubMed ID: 8682457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
